Aarti Industries - Demerger To Unlock Potential Segmental Value: ICICI Direct
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Direct Report
Aarti industries Ltd. board has approved the restructuring of the pharma business and allied activities of the company, which will be demerged into Aarti Pharmalabs Ltd. (formerly known as Aarti Organics Ltd.), a wholly owned subsidiary company of Aarti Industries.
The demerged undertaking also includes a part of the specialty chemical business, which is a backward integrated facility providing feeding material to the pharma business.
This part of the specialty chemical business accounts for less than 3% of revenues of the speciality chemical business.
The demerged company would continue to run and operate the remaining specialty chemical business.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.